Found: 13
Select item for more details and to access through your institution.
Three-dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy.
- Published in:
- Medical Physics, 2012, v. 39, n. 10, p. 6118, doi. 10.1118/1.4752213
- By:
- Publication type:
- Article
Usefulness of specific calibration coefficients for gamma-emitting sources measured by radionuclide calibrators in nuclear medicine.
- Published in:
- Medical Physics, 2011, v. 38, n. 7, p. 4073, doi. 10.1118/1.3596528
- By:
- Publication type:
- Article
A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy.
- Published in:
- Medical Physics, 2011, v. 38, n. 6, p. 2892, doi. 10.1118/1.3576051
- By:
- Publication type:
- Article
REMEDIATION OF RADIUM LEGACIES FROM THE SWISS WATCH INDUSTRY.
- Published in:
- Radiation Protection Dosimetry, 2017, v. 173, n. 1-3, p. 245, doi. 10.1093/rpd/ncw335
- By:
- Publication type:
- Article
Monte Carlo simulation of a whole-body counter using IGOR phantoms.
- Published in:
- Radiation Protection Dosimetry, 2014, v. 162, n. 3, p. 280, doi. 10.1093/rpd/nct336
- By:
- Publication type:
- Article
Biokinetics and dosimetry of In-DOTA-NOC-ATE compared with In-DTPA-octreotide.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2012, v. 39, n. 12, p. 1868, doi. 10.1007/s00259-012-2210-0
- By:
- Publication type:
- Article
First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist <sup>68</sup>Ga-NODAGA-MJ9.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0462-9
- By:
- Publication type:
- Article
Study of the Impact of Tissue Density Heterogeneities on 3-Dimensional Abdominal Dosimetry: Comparison Between Dose Kernel Convolution and Direct Monte Carlo Methods.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 2, p. 236, doi. 10.2967/jnumed.112.105825
- By:
- Publication type:
- Article
Predicting Hematologic Toxicity in Patients Undergoing Radioimmunotherapy with <sup>90</sup>Y-Ibritumomab Tiuxetan or <sup>131</sup>I-Tositumomab.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 12, p. 1878, doi. 10.2967/jnumed.110.079947
- By:
- Publication type:
- Article
Arterial Wall Dosimetry for Non-Hodgkin Lymphoma Patients Treated with Radioimmunotherapy.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 3, p. 368, doi. 10.2967/jnumed.109.069575
- By:
- Publication type:
- Article
MODELLING THE EXPOSURE OF RESIDENTS OF A RADIUM-CONTAMINATED LIVING PLACE.
- Published in:
- Radiation Protection Dosimetry, 2021, v. 197, n. 2, p. 101, doi. 10.1093/rpd/ncab167
- By:
- Publication type:
- Article
Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry.
- Published in:
- Medical Physics, 2008, v. 35, n. 3, p. 1123, doi. 10.1118/1.2836421
- By:
- Publication type:
- Article
Redefining Relative Biological Effectiveness in the Context of the EQDX Formalism: Implications for Alpha-Particle Emitter Therapy.
- Published in:
- Radiation Research, 2014, v. 181, n. 1, p. 90, doi. 10.1667/RR13483.1
- By:
- Publication type:
- Article